Ann Arbor, MI, United States of America

Ashley Reinke

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ashley Reinke

Introduction

Ashley Reinke is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of medical research, particularly in the development of compounds that target plasminogen activator inhibitor-1 (PAI-1). With a total of three patents to her name, Reinke's work is paving the way for advancements in the treatment of various diseases.

Latest Patents

Among her latest patents is the invention of plasminogen activator inhibitor-1 (PAI-1) inhibitor compounds and their methods of use. These compounds are designed to treat diseases or disorders associated with elevated PAI-1 levels. The disclosure includes applications for preventing or reducing thrombosis and fibrosis, promoting thrombolysis, and modulating lipid metabolism. This innovative approach aims to address health issues related to elevated PAI-1, cholesterol, or lipid levels.

Career Highlights

Reinke has worked with esteemed institutions such as the University of Michigan and Eastern Michigan University. Her experience in these research environments has allowed her to collaborate with leading experts in her field and contribute to groundbreaking studies.

Collaborations

Some of her notable coworkers include Daniel Lawrence and Cory Emal. Their collaborative efforts have further enhanced the impact of her research and innovations.

Conclusion

Ashley Reinke's contributions to medical research through her innovative patents highlight her role as a leading inventor in her field. Her work continues to inspire advancements in the treatment of diseases associated with elevated PAI-1 levels.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…